COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY Trademark

Trademark Overview


On Monday, October 16, 2017, a trademark application was filed for COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY with the United States Patent and Trademark Office. The USPTO has given the COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY trademark a serial number of 87646713. The federal status of this trademark filing is REGISTERED as of Tuesday, August 7, 2018. This trademark is owned by Teva Pharmaceutical Industries Limited. The COPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis containing glatiramer acetate
copaxone 40mg/ml (glatiramer acetate injection) three times a week rx only

General Information


Serial Number87646713
Word MarkCOPAXONE 40MG/ML (GLATIRAMER ACETATE INJECTION) THREE TIMES A WEEK RX ONLY
Filing DateMonday, October 16, 2017
Status700 - REGISTERED
Status DateTuesday, August 7, 2018
Registration Number5533589
Registration DateTuesday, August 7, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 22, 2018

Trademark Statements


Description of MarkThe mark consists of a gray band that comes to a point at the bottom right. Inside the band are the words "Rx Only" in small navy letters on the left side of the band. The words "three times a week" in capital navy blue letters to the right of "Rx Only". The word "COPAXONE" in capital navy blue letters to the right of "three times a week". The words "glatiramer acetate injection" in lower case navy blue letters in parenthesis underneath the word "COPAXONE". A gray triangle with a white outline is on the right of the band. Inside the triangle is "40 mg/mL" in navy blue.
Goods and ServicesPharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis containing glatiramer acetate
Indication of Colors claimedThe color(s) gray, white and navy blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text''GLATIRAMER ACETATE INJECTION'' AND ''40 MG/ML'' AND ''THREE TIMES A WEEK'' AND ''RX ONLY''

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2017
Primary Code005
First Use Anywhere DateTuesday, January 28, 2014
First Use In Commerce DateTuesday, January 28, 2014

Trademark Owner History


Party NameTeva Pharmaceutical Industries Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPetach Tikva 49131
IL

Party NameTeva Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Party NameTeva Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events


Event DateEvent Description
Thursday, April 11, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, August 7, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 7, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, May 22, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 18, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, April 18, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, April 18, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, April 18, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, April 9, 2018PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 20, 2018WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 6, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 5, 2018ASSIGNED TO LIE
Tuesday, February 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 23, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 1, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 1, 2018NON-FINAL ACTION E-MAILED
Thursday, February 1, 2018NON-FINAL ACTION WRITTEN
Thursday, January 25, 2018ASSIGNED TO EXAMINER
Thursday, October 26, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, October 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 19, 2017NEW APPLICATION ENTERED